Variant report
Variant | esv18159 |
---|---|
Chromosome Location | chr9:8883454-8884212 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:3)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:3 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | E2F4 | chr9:8883959-8884147 | MCF10A-Er-Src | breast: | n/a | n/a |
2 | STAT3 | chr9:8883359-8883559 | MCF10A-Er-Src | breast: | n/a | n/a |
3 | STAT3 | chr9:8883376-8883576 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000251699 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs539991211 | chr9:8883455-8883456 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs372660045 | chr9:8883457-8883458 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs558408840 | chr9:8883505-8883506 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs570356025 | chr9:8883508-8883509 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs570344379 | chr9:8883509-8883510 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs570984807 | chr9:8883539-8883540 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs528455160 | chr9:8883544-8883545 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs144817868 | chr9:8883547-8883548 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs573927782 | chr9:8883706-8883707 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs118147888 | chr9:8883714-8883715 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs535452374 | chr9:8883742-8883743 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs556477088 | chr9:8883783-8883784 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs73433175 | chr9:8883829-8883830 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs117140057 | chr9:8883830-8883831 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs545166263 | chr9:8883831-8883832 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs535410402 | chr9:8883842-8883843 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs563178666 | chr9:8883863-8883864 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs530707603 | chr9:8883868-8883869 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs542561135 | chr9:8883877-8883878 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs565792407 | chr9:8883892-8883893 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs560853431 | chr9:8883955-8883956 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs148406887 | chr9:8883974-8883975 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs13287579 | chr9:8884015-8884016 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs572471586 | chr9:8884020-8884021 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs557659569 | chr9:8884025-8884026 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs368744964 | chr9:8884031-8884032 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs532137671 | chr9:8884035-8884036 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs551992849 | chr9:8884061-8884062 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs67163376 | chr9:8884063-8884064 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs537641672 | chr9:8884064-8884065 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs556053246 | chr9:8884070-8884071 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs577501079 | chr9:8884075-8884076 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs567879046 | chr9:8884127-8884128 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs117824097 | chr9:8884168-8884169 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs553119535 | chr9:8884186-8884187 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Intracranial aneurysm | 16715129 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 21952639 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
abnormal development | 18461090 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Lung cancer | 20668451 | CNVD |
Schizophrenia | 20838587 | CNVD |
Glioblastoma | 18772890 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:8879600-8886200 | Weak transcription | Brain Cingulate Gyrus | brain |
2 | chr9:8879600-8887000 | Weak transcription | Sigmoid Colon | Sigmoid Colon |
3 | chr9:8880000-8891600 | Weak transcription | Brain Inferior Temporal Lobe | brain |
4 | chr9:8880200-8891800 | Weak transcription | Brain Substantia Nigra | brain |
5 | chr9:8882800-8884400 | Enhancers | Rectal Mucosa Donor 29 | rectum |
6 | chr9:8883000-8884000 | Enhancers | Fetal Intestine Small | intestine |
7 | chr9:8883000-8884400 | Enhancers | Rectal Mucosa Donor 31 | rectum |
8 | chr9:8883200-8884000 | Enhancers | Colonic Mucosa | Colon |
9 | chr9:8883200-8884200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr9:8883400-8883800 | Weak transcription | Fetal Intestine Large | intestine |
11 | chr9:8883400-8884200 | Weak transcription | Duodenum Mucosa | Duodenum |
12 | chr9:8883800-8884000 | Enhancers | Fetal Intestine Large | intestine |
13 | chr9:8884000-8886800 | Weak transcription | Fetal Intestine Small | intestine |
14 | chr9:8884000-8887200 | Weak transcription | Colonic Mucosa | Colon |
15 | chr9:8884000-8887200 | Weak transcription | Fetal Intestine Large | intestine |
16 | chr9:8884200-8884400 | Enhancers | Duodenum Mucosa | Duodenum |